Principal Financial Group Inc. Sells 2,417 Shares of USANA Health Sciences, Inc. (NYSE:USNA)

Principal Financial Group Inc. cut its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 4.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 52,123 shares of the company’s stock after selling 2,417 shares during the quarter. Principal Financial Group Inc. owned 0.27% of USANA Health Sciences worth $1,977,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Exchange Traded Concepts LLC grew its holdings in shares of USANA Health Sciences by 4.4% in the third quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company’s stock worth $292,000 after acquiring an additional 322 shares during the period. Martingale Asset Management L P grew its stake in shares of USANA Health Sciences by 2.1% during the 3rd quarter. Martingale Asset Management L P now owns 16,732 shares of the company’s stock valued at $634,000 after purchasing an additional 340 shares during the period. KBC Group NV grew its stake in shares of USANA Health Sciences by 96.6% during the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after purchasing an additional 519 shares during the period. Safe Harbor Fiduciary LLC purchased a new stake in shares of USANA Health Sciences during the 3rd quarter valued at about $30,000. Finally, Public Sector Pension Investment Board lifted its stake in shares of USANA Health Sciences by 5.4% in the 2nd quarter. Public Sector Pension Investment Board now owns 24,270 shares of the company’s stock worth $1,098,000 after purchasing an additional 1,242 shares during the period. 54.25% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

USNA has been the topic of several recent research reports. DA Davidson increased their price target on shares of USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research report on Thursday. StockNews.com raised USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Saturday, December 28th.

Insider Buying and Selling at USANA Health Sciences

In other news, Director Gilbert A. Fuller sold 675 shares of the business’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $37.71, for a total value of $25,454.25. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.33% of the company’s stock.

USANA Health Sciences Price Performance

Shares of USNA stock opened at $36.17 on Friday. USANA Health Sciences, Inc. has a one year low of $31.44 and a one year high of $52.75. The company’s fifty day moving average price is $37.86 and its 200-day moving average price is $39.59. The company has a market capitalization of $689.40 million, a price-to-earnings ratio of 12.78, a PEG ratio of 1.25 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, beating the consensus estimate of $0.49 by $0.07. The business had revenue of $200.22 million for the quarter, compared to the consensus estimate of $208.45 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. During the same period in the previous year, the business earned $0.59 earnings per share. Equities research analysts expect that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.